COMMUNIQUÉS West-GlobeNewswire

OV’s method can predict if neoadjuvant treatment with doxorubicin in breast cancer will be successful, data published in ASCO journal
04/06/2019
Investor News Hoersholm, Denmark and Cambridge, MA, US, June 4, 2019. – Oncology Venture A/S (“OV” or “the Company”) today announced that an e-abstract has been published in Journal of Clinical Oncology – an ASCO [...]
Verona Pharma Initiates Phase 2 Clinical Trial with Metered Dose Inhaler Formulation of Ensifentrine for Maintenance Treatment of COPD
04/06/2019
Ensifentrine delivery via MDI inhalers could dramatically expand clinical utility and commercial opportunity LONDON, June 04, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a [...]
ObsEva SA Announces Completion of Patient Recruitment in IMPLANT 4 Phase 3 Clinical Trial of Nolasiban for Improving IVF Outcomes
04/06/2019
Geneva, Switzerland and Boston, MA – June 4, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Sequana Medical Announces Unconditional IDE Approval from U.S. FDA to Start alfapump® Pivotal Study (POSEIDON)
04/06/2019
alfa pump pivotal study for treatment of recurrent or refractory ascites due to liver cirrhosis Optimised clinical trial design of up to 50 patients implanted with alfa pump in study cohort and shorter follow-up time [...]
MedMira Announces AGM Results
04/06/2019
HALIFAX, Nova Scotia, June 03, 2019 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) held its 2019 Annual General Meeting of Shareholders on May 31, 2019 in Halifax, Nova Scotia. Incumbent Director Mr. Hermes Chan [...]
Veloxis Increases Share Capital in Connection with Exercise of Warrants
03/06/2019
Company Release no. 10/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 June 2019 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company's [...]
National Research Corporation Declares Quarterly Dividend
03/06/2019
Lincoln, Nebraska, June 03, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.19 (nineteen cents) per share [...]
Adamas to Present at Upcoming JMP Investor Conference
03/06/2019
EMERYVILLE, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system disorders, [...]
Meridian Bioscience Announces Closing of Transaction to Acquire Business of GenePOC
03/06/2019
CINCINNATI, June 03, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has completed its previously [...]
Meeting of Holders of Debentures Issued by Golden Leaf Holdings to be Held
03/06/2019
TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a pioneer cannabis company built around recognized brands for the wellness and recreational markets [...]
Dynavax to Present at the William Blair & Co. Annual Growth Stock Conference
03/06/2019
BERKELEY, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), today announced that Ryan Spencer, Senior Vice President, Commercial, and Interim Co-President, will present at the [...]
Scholar Rock Announces Positive Final Results from Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers
03/06/2019
- SRK-015 was well-tolerated in healthy volunteers across all tested doses, supporting evaluation in the ongoing Phase 2 TOPAZ trial in Spinal Muscular Atrophy (SMA) - Pharmacodynamic results from the completed multiple [...]
Sientra Commences Public Offering of Common Stock
03/06/2019
SANTA BARBARA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that it has commenced an underwritten public follow-on [...]
Oncternal Therapeutics Announces Updated Interim Data from a Phase 1/2 Study of Cirmtuzumab in Combination with Ibrutinib
03/06/2019
Data presented today at the 2019 American Society of Clinical Oncology Annual Meeting SAN DIEGO, June 03, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., a clinical-stage biotechnology company focused on [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
03/06/2019
COPENHAGEN, Denmark, June 3, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on May 22, 2019, has now been terminated, as the intended [...]
CORRECTION -- Strateos combines Transcriptic and 3Scan to become Premier Drug Discovery Technology Partner for the Pharmaceutical Industry
03/06/2019
Industry Leader Mark Fischer-Colbrie appointed as Chief Executive Officer SAN FRANCISCO, June 03, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Strateos, please note that the link [...]
Ontario Pharmacists Association Announces Recipients of Lifetime Achievement and Pharmacist of the Year Awards
03/06/2019
TORONTO, June 03, 2019 (GLOBE NEWSWIRE) -- The Ontario Pharmacists Association (OPA) is pleased to announce that David Windross of Toronto is the recipient of the 2019 Lifetime Achievement Award and John Girgis of [...]
Overall Response Rate of 76% in Advanced Melanoma Patients with Dynavax’s SD-101 in Combination with KEYTRUDA® (pembrolizumab); Data Presented Today at the 2019 ASCO Annual Meeting
03/06/2019
Progression Free Survival (PFS) rate of 18-months in 72% of patients Clinical efficacy in patients with immunologically cold tumor at baseline The combination of SD-101 and pembrolizumab was well-tolerated, consistent [...]
Strateos combines Transcriptic and 3Scan to become Premier Drug Discovery Technology Partner for the Pharmaceutical Industry
03/06/2019
Industry Leader Mark Fischer-Colbrie appointed as Chief Executive Officer SAN FRANCISCO, June 03, 2019 (GLOBE NEWSWIRE) -- The boards of Transcriptic and 3Scan have unanimously approved an agreement to merge companies [...]

Pages